Evidence map›Paper›PMID 40479203›Full record

ArticleRevista espanola de anestesiologia y reanimacion2020

Clinical consensus recommendations regarding non-invasive respiratory support in the adult patient with acute respiratory failure secondary to SARS-CoV-2 infection.

C Cinesi Gómez, Ó Peñuelas Rodríguez, M L Luján Torné, C Egea Santaolalla, J F Masa Jiménez, J García Fernández, J M Carratalá Perales, S B Heili-Frades, M Ferrer Monreal, J M de Andrés Nilsson and 15 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Revista espanola de anestesiologia y reanimacion, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

C Cinesi GómezDirección General de Asistencia Sanitaria, Servicio Murciano de Salud, Director del Máster Oficial en Medicina de Urgencias y Emergencias, Murcia, Spain.
Ó Peñuelas RodríguezServicio de Medicina Intensiva y Grandes Quemados, Hospital Universitario de Getafe, CIBER de Enfermedades Respiratorias, CIBERES, Getafe, Madrid, Spain.
M L Luján TornéServicio de Neumología, Hospital de Sabadell, Corporació Parc Taulí, Universitat Autònoma de Barcelona, Centro de Investigación Biomédica en Red (CIBERES), Sabadell, Barcelona, Spain.
C Egea SantaolallaUnidad Funcional de Sueño, Hospital Universitario ARaba, OSI araba, Vitoria-Gasteiz, Spain.
J F Masa JiménezServicio de Neumología, Hospital San Pedro de Alcántara, CIBER de Enfermedades Respiratorias (CIBERES), Instituto Universitario de Investigación Biosanitaria de Extremadura (INUBE), Cáceres, Spain.
J García FernándezServicio de Anestesia, Cuidados Críticos Quirúrgicos y Dolor, Hospital Universitario Puerta de Hierro, Madrid, Spain.
J M Carratalá PeralesServicio de Urgencias, Unidad de Corta Estancia y Hospitalización a Domicilio, Hospital General de Alicante, Instituto de Investigación Sanitaria y Biomédica de Alicante (ISABIAL-Fundación FISABIO), Alicante, Spain.
S B Heili-FradesJefe Asociado de Neumología, responsable de la UCIR, Hospital Universitario Fundación Jiménez Díaz, CIBERES, REVA, EMDOS, Madrid, Spain.
M Ferrer MonrealServei de Pneumologia, Institut Clínic de Respiratori, Hospital Clínic de Barcelona, IDIBAPS, CibeRes (CB06/06/0028), Universitat de Barcelona, Barcelona, Spain.
J M de Andrés NilssonServicio de Urgencias, Hospital Royo Villanova, Zaragoza, Spain.
E Lista AriasServicio de Urgencias, Parc Taulí Hospital Universitari, Sabadell, Barcelona, Spain.
J L Sánchez RocamoraServicio de Urgencias, Hospital General de Villarrobledo, Villarrobledo, Albacete, Spain.
J I GarroteMédico de Emergencias GUETS, SESCAM, Coordinador docente Eliance, Spain.
M J Zamorano SerranoMédico Adjunto de Urgencias, Hospital Ramón y Cajal, Madrid, Spain.
M González MartínezUnidad de Sueño y Ventilación, Neumología, Hospital Universitario Marqués de Valdecilla, IDIVAL, Universidad de Cantabria, Santander, Spain.
E Farrero MuñozServei de Pneumologia, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.
O Mediano San AndrésUnidad del Sueño, Neumología, Hospital Universitario de Guadalajara, Guadalajara, Spain.
G Rialp CerveraServicio de Medicina Intensiva, Hospital Universitari Son Llàtzer, Palma de Mallorca, Spain.
A Mas SerraServei de Medicina Intensiva, Hospital de Sant Joan Despí Moisès Broggi, Hospital General d'Hospitalet, Sant Joan Despí, Barcelona, Spain.
G Hernández MartínezServicio de Medicina Intensiva, Hospital Universitario Virgen de la Salud, Toledo, Spain.
C de Haro LópezÁrea de Críticos, Corporació Sanitària i Universitària Parc Taulí, CIBER Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Sabadell, Barcelona, Spain.
O Roca GasServicio de Medicina Intensiva, Hospital Universitario Vall d'Hebron, Institut de Recerca Vall d'Hebron, Universitat Autònoma de Barcelona, Ciber Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Barcelona, Spain.
R Ferrer RocaServicio de Medicina Intensiva, Hospital Universitario Vall d'Hebron, Shock, Organ Dysfunction and Resuscitation Research Group, Vall d'Hebron Institut de Recerca, CIBER de Enfermedades Respiratorias, CIBERES, Barcelona, Spain.
A Romero BerrocalServicio de Anestesia y Reanimación, Hospital Universitario Puerta de Hierro, Madrid, Spain.
C Ferrando OrtolaJefe de Sección Área de Cuidados Intensivos Quirúrgicos, Servicio de Anestesia y Cuidados Intensivos, Hospital Clínic, Barcelona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) is a respiratory tract infection caused by a newly emergent coronavirus, that was first recognized in Wuhan, China, in December 2019. Currently, the World Health Organization (WHO) has defined the infection as a global pandemic and there is a health and social emergency for the management of this new infection. While most people with COVID-19 develop only mild or uncomplicated illness, approximately 14% develop severe disease that requires hospitalization and oxygen support, and 5% require admission to an intensive care unit. In severe cases, COVID-19 can be complicated by the acute respiratory distress syndrome (ARDS), sepsis and septic shock, and multiorgan failure. This consensus document has been prepared on evidence-informed guidelines developed by a multidisciplinary panel of health care providers from four Spanish scientific societies (

Indexed as

Aerosol-generating proceduresHigh-flow nasal therapyInfection controlNon-invasive mechanical ventilation

Identifiers

PMID40479203
PMCPMC7203031

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.